Document Detail


Hypercoagulability: a cause of vascular access failure.
MedLine Citation:
PMID:  552047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a group of 58 patients requiring tertiary vascular access procedures for maintenance of hemodialysis, 29 patients who thrombosed well-functioning fistulas were evaluated for both antithrombin deficiencies as well as platelet hyperaggreability. Thirteen of these 29 patients were found to have one or more coagulation defects. Following correction of the hypercoagulable state, tertiary vascular access procedures, using autologous tissues, were 100% successful in these 13 patients.
Authors:
H M Kauffman; G A Ekbom; M B Adams; C V Hussey
Related Documents :
23345077 - First clinical experience with intranasal cooling for hyperthermia in brain-injured pat...
1683377 - Hypersensitivity to acetate dialysate: report of a case.
2645537 - Specific imaging of dialysis-related amyloid deposits using 131i-beta-2-microglobulin.
19820127 - Cmv seropositivity determines epoetin dose and hemoglobin levels in patients with ckd.
22089467 - Proposed severity and response criteria for routine assessment of patient index data (r...
15143747 - Non-specific bronchial hyperresponsiveness is a risk factor for steroid insensitivity i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Proceedings of the Clinical Dialysis and Transplant Forum     Volume:  9     ISSN:  0094-6044     ISO Abbreviation:  Proc Clin Dial Transplant Forum     Publication Date:  1979  
Date Detail:
Created Date:  1980-12-18     Completed Date:  1980-12-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0432324     Medline TA:  Proc Clin Dial Transplant Forum     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  28-31     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antithrombin III Deficiency
Aspirin / therapeutic use
Dipyridamole / therapeutic use
Humans
Intraoperative Period
Plasma
Renal Dialysis / adverse effects*,  methods
Thrombosis / etiology*,  prevention & control
Time Factors
Veins / surgery*
Chemical
Reg. No./Substance:
50-78-2/Aspirin; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subclavian cannula for temporary hemodialysis.
Next Document:  Ischemic heart disease in the hemodialysis population.